Login to Your Account



Other News To Note


Thursday, May 3, 2012
• Mirna Therapeutics Inc., of Austin, Texas, reported data demonstrating that microRNA-34 (miR-34) mimics inhibited tumor growth in an animal model of B-cell lymphoma. The data, published in Leukemia, complemented those generated by Mirna and academic collaborators in animal models of lung and prostate cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription